Atlas Trials

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Clinical trial NCT00329368 · COMPLETED

Trial details

NCT number
NCT00329368
Sponsor
Endocyte
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2005-09-01
Primary completion
2007-12-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.